This medcine is indicated in chronic stable angina (consistent duration and severity of brief episodes of pain, pressure, squeezing and tightness in chest), coronary artery disease (narrowing or blockage of arteries of heart muscles) with normal sinus rhythm (normal heart rate) who have a contraindication or intolerance to beta blockers when mon...

Symptomatic treatment of chronic heart failure of NYHA Classes II or III and with documented left ventricular ejection fraction (LVEF) ≤ 35% in adult patients in sinus rhythm and with heart rate at or above 77 bpm, in combination with optimal standard chronic heart failure treatment.

Sivab (Ivabradine) Tablets are indicated for the treatment of: Coronory Artery Disease (CAD) Symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm: - Who are unable to tolerate or have a contraindication to beta blockers, or - In combination with beta-blockers in patients inadequately

Sivab 5 mg Tablets facilitate the individuals with chronic heart failure to lessen the probability of institutionalization for deteriorating heart failure. Heart failure in children 6 months and older, with symptoms caused by an enlarged heart, may also be treated with this medication.

Sivab 5 mg tablet, containing Ivabradine, is a vital cardiac therapy medication for managing chronic heart failure and systolic dysfunction, providing relief and improved cardiac well-being.

Sivab tablet is primarily used for the treatment of heart failure. You should know the risks and warnings of Sivab to prevent its misuse. There are some specific circumstances under which …

Sivab 5mg Tablet is an effective antiarrhythmic and antianginal drug. Its use is indicated for the treatment and management of stable angina pectoris in patients with coronary artery disease (CAD) with or without beta-blockers, and chronic heart failure.

Sivab 5mg Tablet is an effective antiarrhythmic and antianginal drug. Its use is indicated for the treatment and management of stable angina pectoris in patients with coronary artery disease (CAD) with or without beta-blockers, and chronic heart failure.

Ivabradine is a unique heart rate-lowering agent that works by targeting the If current in the sodium-gated channels in cardiac myocytes. It reduces the heart rate through a different mechanism of action than traditional heart rate lowering agents, such as beta-blockers or calcium channel blockers.

Sivab 5 mg: One film-coated tablet contains 5 mg Sivab (equivalent to 5.390 mg Sivab as hydrochloride). Sivab 7.5 mg: One film-coated tablet contains 7.5 mg Sivab (equivalent to 8.085 mg Sivab hydrochloride).